In addition, the utility of FBLN5 should be investigated in liver fibrosis with etiologies other than hepatitis C. While we conducted snRNA-seq analysis to confirm upregulation of FBLN5 in steatotic liver disease, more comprehensive studies are needed. Here, FBLN5 is linked to liver disorder.